Abstract
The aim of this study is optimization of experimental factors in a UV-visible spectrophotometric method for simultaneous determination of dorzolamide hydrochloride and timolol maleate in eye drops. For this purpose, partial least squares-1 method was developed for resolving overlapped UV-visible spectra of these compounds. Principal component number, wavelength range (number of wavelengths) and data preprocessing applications were investigated as experimental factors. The affected experimental response in this method is PRESS (Prediction Error Sum of Squares) values. Response Surface Methodology (RSM) method was used for interpretation of relationships between these factors and PRESS values, and results were shown as equations and contour graphs. Multivariate calibration techniques which were used in the method development have some advantages such as using whole spectrum for the simultaneous analysis of the mixture component that allow to minimize the effects of noise peak, shorter analysis time, low cost and simple instrumentation without any chemical pre-treatment. This optimized method was validated and applied to a pharmaceutical preparation, eye drops, and results were compared with a literature method statistically and no significant difference was observed.
Keywords: Multivariate optimization, PLS-1, validation, pharmaceutical preparation, dorzolamide hydrochloride, timolol maleate, eye drops.
Current Pharmaceutical Analysis
Title:Multivariate Optimization Model in a Partial Least Squares-1 Method for Simultaneous Determination of Dorzolamide Hydrochloride and Timolol Maleate in Eye Drops
Volume: 9 Issue: 4
Author(s): Ismail Murat Palabiyik, Ece Goker, Mehmet Gokhan Caglayan and Feyyaz Onur
Affiliation:
Keywords: Multivariate optimization, PLS-1, validation, pharmaceutical preparation, dorzolamide hydrochloride, timolol maleate, eye drops.
Abstract: The aim of this study is optimization of experimental factors in a UV-visible spectrophotometric method for simultaneous determination of dorzolamide hydrochloride and timolol maleate in eye drops. For this purpose, partial least squares-1 method was developed for resolving overlapped UV-visible spectra of these compounds. Principal component number, wavelength range (number of wavelengths) and data preprocessing applications were investigated as experimental factors. The affected experimental response in this method is PRESS (Prediction Error Sum of Squares) values. Response Surface Methodology (RSM) method was used for interpretation of relationships between these factors and PRESS values, and results were shown as equations and contour graphs. Multivariate calibration techniques which were used in the method development have some advantages such as using whole spectrum for the simultaneous analysis of the mixture component that allow to minimize the effects of noise peak, shorter analysis time, low cost and simple instrumentation without any chemical pre-treatment. This optimized method was validated and applied to a pharmaceutical preparation, eye drops, and results were compared with a literature method statistically and no significant difference was observed.
Export Options
About this article
Cite this article as:
Palabiyik Murat Ismail, Goker Ece, Caglayan Gokhan Mehmet and Onur Feyyaz, Multivariate Optimization Model in a Partial Least Squares-1 Method for Simultaneous Determination of Dorzolamide Hydrochloride and Timolol Maleate in Eye Drops, Current Pharmaceutical Analysis 2013; 9 (4) . https://dx.doi.org/10.2174/1573412911309040008
DOI https://dx.doi.org/10.2174/1573412911309040008 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
An Increasing Incidence of Treatment Resistance in Hypertension?
Current Drug Therapy Crystal Structure of Bucain, a Three-Fingered Toxin from the Venom of the Malayan Krait (Bungarus candidus)
Protein & Peptide Letters Hypogonadotrophic Hypogonadism in Type 2 Diabetes, Obesity and the Metabolic Syndrome
Current Molecular Medicine Development and Characterization Pulsatile Microspheres of Nifedipine for Hypertension
Recent Patents on Drug Delivery & Formulation An Apple Plus a Brazil Nut a Day Keeps the Doctors Away: Antioxidant Capacity of Foods and their Health Benefits
Current Pharmaceutical Design Discovery of Potent, Non-Steroidal and Highly Selective Glucocorticoid Receptor Antagonists with Anti-Obesity Activity
Letters in Drug Design & Discovery The Role of Mitochondrial Dysfunction in Heart Failure and Potential Therapeutic Targets
Current Pharmaceutical Design Inhibition of the Calcineurin-NFAT Signalling Cascade in the Treatment of Heart Failure
Recent Patents on Cardiovascular Drug Discovery A Facile Synthesis of Polyhydroquinoline Derivatives via the Hantzsch Reaction Under Solvent Free-Conditions Using Potassium Dodecatungsto Cobaltate Trihydrate (K5CoW12O40.3H2O)
Letters in Organic Chemistry Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women
Recent Patents on Anti-Cancer Drug Discovery Matrix Metalloproteinases as Drug Targets in Acute Pulmonary Embolism
Current Drug Targets Conference Report: 7th Clinical Trials on Alzheimer’s Disease Annual Conference, Philadelphia, PA, USA Nov 20-22, 2014
CNS & Neurological Disorders - Drug Targets Role of Carbon Monoxide in Vascular Diseases
Current Pharmaceutical Biotechnology Attenuation of Diabetes-induced Cardiac and Subcellular Defects by Sulphur-containing Amino Acids
Current Medicinal Chemistry Micro-RNAs, Exercise and Cellular Plasticity in Humans: The Impact of Dietary Factors and Hypoxia
MicroRNA Outcome Prediction after Non-aneurysmal Non-traumatic Subarachnoid Hemorrhage
Current Neurovascular Research Recommendations for the Treatment of Hypertension in Patients with DM: Critical Evaluation Based on Clinical Trials
Current Clinical Pharmacology Crocin Protects Against Beta-Amyloid Peptide-Induced Apoptosis in PC12 Cells Via the PI3 K Pathway
Current Molecular Pharmacology Editorial (Thematic Issue: The Crosstalk between Non-Pharmaceutical and Pharmaceutical Approaches to Prevention and Treatment of Chronic Diseases: Current Concepts and Perspectives)
Current Pharmaceutical Design Antenatal Maternal Antidepressants Drugs Affect S100B Concentrations in Fetal-Maternal Biological Fluids
CNS & Neurological Disorders - Drug Targets